There are inconsistencies in the literature regarding the prevalence and assessment of chemotherapyinduced peripheral neuropathy (CIPN). This study explored CIPN natural history and its characteristics in patients receiving taxane- and platinum-based chemotherapy. | Are we mis-estimating chemotherapyinduced peripheral neuropathy Analysis of assessment methodologies from a prospective multinational longitudinal cohort study of patients receiving neurotoxic chemotherapy